What is the liver cirrhosis treatment market size in 2026?

The global liver cirrhosis treatment market is projected to reach US$16.1 billion in 2026.

What drives the liver cirrhosis treatment market?

Increasing cases of NASH, viral hepatitis, and alcohol-related cirrhosis are driving demand for effective treatment options, including antibiotics, immunosuppressants, and antifibrotic therapies.

What is the growth rate for the liver cirrhosis treatment market?

The liver cirrhosis treatment market is poised to witness a CAGR of 7.1% from 2026 to 2033.

What are the key market opportunities?

Development of antifibrotic agents, novel immunosuppressants, and personalized combination treatments presents opportunities for improved patient outcomes and expansion in both developed and emerging markets.

Who are the key players in the liver cirrhosis treatment market?

Gilead Sciences, AbbVie, Novartis, Merck & Co., and Bristol-Myers Squibb are the key players.

Table of Content - Liver Cirrhosis Treatment Market Size, Share, and Growth Forecast, 2026

Executive Summary
1. Global Liver Cirrhosis Treatment Market Snapshot, 2026 and 2033
2. Market Opportunity Assessment, 2026 – 2033, US$ Bn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Challenges
  5. Key Trends
3. COVID-19 Impact Analysis
4. Forecast Factors – Relevance and Impact
Value Added Insights
1. Value Chain Analysis
2. Key Market Players
3. Regulatory Landscape
4. PESTLE Analysis
5. Porter’s Five Force Analysis
6. Consumer Behavior Analysis
Price Trend Analysis, 2020-2025
1. Key Factors Impacting Product Prices
2. Pricing Analysis, By Treatment Type
3. Regional Prices and Product Preferences
Global Liver Cirrhosis Treatment Market Outlook
1. Market Size (US$ Bn) Analysis and Forecast
  1. Historical Market Size (US$ Bn) Analysis, 2020-2025
  2. Market Size (US$ Bn) Analysis and Forecast, 2026–2033
2. Global Liver Cirrhosis Treatment Market Outlook: Treatment Type
  1. Historical Market Size (US$ Bn) Analysis, By Treatment Type, 2020-2025
  2. Market Size (US$ Bn) Analysis and Forecast, By Treatment Type, 2026–2033
    1. Antibiotics
    2. Immunosuppressants
    3. Others
  3. Market Attractiveness Analysis: Treatment Type
3. Global Liver Cirrhosis Treatment Market Outlook: End-user
  1. Historical Market Size (US$ Bn) Analysis, By End-user, 2020-2025
  2. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2026–2033
    1. Hospitals & Clinics
    2. Research and Academic Institutes
    3. Others
  3. Market Attractiveness Analysis: End-user
Global Liver Cirrhosis Treatment Market Outlook: Region
1. Historical Market Size (US$ Bn) Analysis, By Region, 2020-2025
2. Market Size (US$ Bn) Analysis and Forecast, By Region, 2026–2033
  1. North America
  2. Latin America
  3. Europe
  4. East Asia
  5. South Asia and Oceania
  6. Middle East & Africa
3. Market Attractiveness Analysis: Region
North America Liver Cirrhosis Treatment Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Treatment Type
  3. By End-user
2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026–2033
  1. U.S.
  2. Canada
3. Market Size (US$ Bn) Analysis and Forecast, By Treatment Type, 2026–2033
  1. Antibiotics
  2. Immunosuppressants
  3. Others
4. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2026–2033
  1. Hospitals & Clinics
  2. Research and Academic Institutes
  3. Others
Europe Liver Cirrhosis Treatment Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Treatment Type
  3. By End-user
2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026–2033
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Rest of Europe
3. Market Size (US$ Bn) Analysis and Forecast, By Treatment Type, 2026–2033
  1. Antibiotics
  2. Immunosuppressants
  3. Others
4. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2026–2033
  1. Hospitals & Clinics
  2. Research and Academic Institutes
  3. Others
5. Market Attractiveness Analysis
East Asia Liver Cirrhosis Treatment Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Treatment Type
  3. By End-user
2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026–2033
  1. China
  2. Japan
  3. South Korea
3. Market Size (US$ Bn) Analysis and Forecast, By Treatment Type, 2026–2033
  1. Antibiotics
  2. Immunosuppressants
  3. Others
4. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2026–2033
  1. Hospitals & Clinics
  2. Research and Academic Institutes
  3. Others
5. Market Attractiveness Analysis
South Asia & Oceania Liver Cirrhosis Treatment Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Treatment Type
  3. By End-user
2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026–2033
  1. India
  2. Indonesia
  3. Thailand
  4. Singapore
  5. ANZ
  6. Rest of South Asia & Oceania
3. Market Size (US$ Bn) Analysis and Forecast, By Treatment Type, 2026–2033
  1. Antibiotics
  2. Immunosuppressants
  3. Others
4. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2026–2033
  1. Hospitals & Clinics
  2. Research and Academic Institutes
  3. Others
5. Market Attractiveness Analysis
Latin America Liver Cirrhosis Treatment Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Treatment Type
  3. By End-user
2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026–2033
  1. Brazil
  2. Mexico
  3. Rest of Latin America
3. Market Size (US$ Bn) Analysis and Forecast, By Treatment Type, 2026–2033
  1. Antibiotics
  2. Immunosuppressants
  3. Others
4. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2026–2033
  1. Hospitals & Clinics
  2. Research and Academic Institutes
  3. Others
5. Market Attractiveness Analysis
Middle East & Africa Liver Cirrhosis Treatment Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2020-2025
  1. By Country
  2. By Treatment Type
  3. By End-user
2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026–2033
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
3. Market Size (US$ Bn) Analysis and Forecast, By Treatment Type, 2026–2033
  1. Antibiotics
  2. Immunosuppressants
  3. Others
4. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2026–2033
  1. Hospitals & Clinics
  2. Research and Academic Institutes
  3. Others
5. Market Attractiveness Analysis
Competition Landscape
1. Market Share Analysis, 2025
2. Market Structure
  1. Competition Intensity Mapping By Market
  2. Competition Dashboard
3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
  1. Gilead Sciences
    1. Overview
    2. Segments and Treatment Type
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. AbbVie
  3. Bristol-Myers Squibb
  4. Merck & Co.
  5. Novartis
  6. Roche
  7. Amgen
  8. Eisai
  9. Hepion Pharmaceuticals
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Liver Cirrhosis Treatment Market Size, Share, and Growth Forecast, 2026 - 2033

Liver Cirrhosis Treatment Market by Treatment (Antibiotics, Immunosuppressants, Others), End-user (Hospitals & Clinics, Research and Academic Institutes, Others), and Regional Analysis for 2026 – 2033

Quick Links

Our Partners

Secure Payments Through